Touradji Capital Management’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Touradji Capital Management’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-13,500	Closed	-$85K	–	81
2013 Q2	$85K	Buy	+13,500	New	+$80.9K	0.32%	57

Other funds holding PBTH

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Touradji Capital Management's PBTH Position: Q3 2013 in Review

Touradji Capital Management sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 13,500 shares — an estimated $85K sold.

Touradji Capital Management first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $85K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Touradji Capital Management reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Touradji Capital Management sold 13,500 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $85K.
Touradji Capital Management first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Touradji Capital Management's PROLOR Biotech, Inc. Common Stock position peaked at $85K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Touradji Capital Management's 13F filing for Q3 2013, filed 28 Oct 2013.